Novartis AG vs. Bausch & Lomb
This article was originally published in The Gray Sheet
Executive Summary
Ciba Vision parent files patent infringement suit in Dublin alleging B&L PureVision extended-wear contact lenses infringe Irish Patent 819258 for Ciba's Focus Night & Day lenses. The firm is seeking an injunction on all manufacturing and sales. B&L world manufacturing headquarters for PureVision are located in Waterford, Ireland; the firm moved the plant from its Rochester, N.Y. site last year. B&L may not make or sell the lenses in the U.S. until April 2005, following a verdict on a separate patent case (1"The Gray Sheet" Feb. 17, 2003, p. 11). If Ciba prevails in Ireland, PureVision would be banned from the country until 2016. A similar suit involving the "Nicolson" patent is ongoing in federal district court in Gainesville, Ga.; a trial date will be set this year. The Nicolson patent expires in 2014...
You may also be interested in...
Wesley Jessen Wins PureVision Patent Suit; B&L Weighs Limited Options
Bausch & Lomb is prohibited from selling its PureVision extended-wear contact lenses in the U.S. following a Washington, D.C. federal appeals court ruling Feb. 12
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.